Records containing: Leiomyosarcoma

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

All FDA submission records EMA medicine records ClinicalTrials.gov record updates ClinicalTrials.gov records with results posted

CLINICAL_TRIALS study record update · 2021-11-01
A Phase II Study on Trabectedin in Advanced Retroperitoneal Leiomyosarcoma and Well Differentiated/Dedifferentiated Liposarcoma
CLINICAL_TRIALS study record update · 2021-09-05
Prospective, National and Multicenter Biomedical Study of Cohorts, Aimed at Patients With Surgical Indication of Hysterectomy, Laparoscopic or Laparotomic Myomectomy Due to Diagnosis of Myometrial Tumors (Leiomyoma / Leiomyosarcoma)
CLINICAL_TRIALS study record update · 2021-08-31
A Phase 1a/1b Study of LY3435151 Administered to Patients With Advanced Solid Tumors
CLINICAL_TRIALS study record update · 2021-07-28
A Phase 2 Study of 9-ING-41, a Glycogen Synthase Kinase-3 Beta (GSK-3β) Inhibitor, Combined With Chemotherapy in Adolescents and Adults With Advanced Sarcomas
CLINICAL_TRIALS study record update · 2021-02-01
Hypofractionated Radiotherapy With Hyperthermia in Unresectable or Marginally Resectable Soft Tissue Sarcomas
Organize your saved records without ads with Plus.
CLINICAL_TRIALS study record update · 2021-01-22
Hypofractionated 5x5 Gy Radiotherapy With Sequential Doxorubicin and Ifosfamide-based Chemotherapy in Marginally Resectable Soft Tissue Sarcomas of Extremities or Trunk Wall
CLINICAL_TRIALS study record update · 2020-10-09
Pazopanib Neoadjuvant Trial in Non-Rhabdomyosarcoma Soft Tissue Sarcomas (PAZNTIS): A Phase II/III Randomized Trial of Preoperative Chemoradiation or Preoperative Radiation Plus or Minus Pazopanib (NSC# 737754)
CLINICAL_TRIALS study record update · 2020-10-09
Pazopanib Neoadjuvant Trial in Non-Rhabdomyosarcoma Soft Tissue Sarcomas (PAZNTIS): A Phase II/III Randomized Trial of Preoperative Chemoradiation or Preoperative Radiation Plus or Minus Pazopanib (NSC# 737754)
CLINICAL_TRIALS study record update · 2020-07-27
A Pilot Study of Peroral Vorinostat (SAHA) in Patients With Refractory Histone Deacetylase-positive Uterine Sarcoma
CLINICAL_TRIALS study record update · 2020-02-07
Most Closely HLA-Matched Allogeneic LMP1/2-Specific Cytotoxic T Lymphocytes for Treatment of Patients With Relapsed EBV-Associated Diseases
CLINICAL_TRIALS study record update · 2020-02-07
Administration of LMP-Specific Cytotoxic T-Lymphocytes to Patients With Relapsed EBV-Positive Lymphoma (ALCI) / Previously Known as: Administration of Neomycin Resistance Gene Marked LMP2A-Specific Cytotoxic T-Lymphocytes to Patents With Relapsed EBV-Positive Lymphoma (ALASCAR)
CLINICAL_TRIALS study record update · 2020-01-31
Phase II Multicenter Study to Determine the Efficacy of Gemcitabine With Pazopanib as Second Line Treatment in Patients With Metastatic or Relapsed Uterine or Soft Tissue Leiomyosarcomas
CLINICAL_TRIALS study record update · 2019-05-13
Time to Secondary Resistance to Trabectedin After Interruption Versus Continuation in Responding Patients With Liposarcoma, Leiomyosarcoma and Synovial Sarcoma
CLINICAL_TRIALS study record update · 2019-03-18
A Phase I Study of Trabectedin in Combination With Fixed Doses of Doxorubicin and Olaratumab in Patients With Metastatic or Recurrent Leiomyosarcoma
CLINICAL_TRIALS study record update · 2018-10-11
A Randomized Phase II Study of Letrozole Versus Observation in Patients With Newly Diagnosed Uterine Leiomyosarcoma
CLINICAL_TRIALS study record update · 2018-07-17
A Five-Tier, Phase 2 Open-Label Study of IMC-A12 Administered as a Single Agent Every 2 Weeks in Patients With Previously-Treated, Advanced or Metastatic Soft Tissue and Ewing's Sarcoma/PNET
CLINICAL_TRIALS study record update · 2018-07-02
Detection of Circulating Tumor Cells in Patients With Metastatic Sarcomas
CLINICAL_TRIALS study record update · 2017-12-06
A Phase II Randomized - Non Comparative - Study on the Activity of Trabectedin or Gemcitabine + Docetaxel in Metastatic or Locally Relapsed Uterine Leiomyosarcoma Pretreated With Conventional Chemotherapy
CLINICAL_TRIALS study record update · 2017-05-19
A Phase II Study of Neoadjuvant Bevacizumab and Radiation Therapy for Resectable Soft Tissue Sarcomas
CLINICAL_TRIALS study record update · 2017-02-14
Phase II Study Evaluating PegLiposomal Doxorubicin (PLD) and Carboplatin Combination Chemotherapy in Gynecological Sarcomas and Mixed Epithelial-Mesenchymal Tumors
CLINICAL_TRIALS study record update · 2016-02-17
A Phase IB/II Study of Gemcitabine and Docetaxel in Combination With Pazopanib (Gem/Doce/Pzb) for the Neoadjuvant Treatment of Soft Tissue Sarcoma (STS)
CLINICAL_TRIALS study record update · 2016-01-25
Phase II Trial Of Gemcitabine and Docetaxel With Bevacizumab in Selected Sarcoma Subtypes
CLINICAL_TRIALS study record update · 2015-11-20
Phase II Trial of Sorafenib and Dacarbazine in Soft Tissue Sarcoma
CLINICAL_TRIALS study record update · 2015-02-13
A Phase II Study of AP23573, An mTOR Inhibitor, in Patients With Advanced Sarcoma
CLINICAL_TRIALS study record update · 2014-12-16
Phase I Dose Escalating Trial Evaluating the Combination of Gemcitabine and Trabectedin in Patients With Advanced and/or Metastatic Leiomyosarcoma or Liposarcoma